UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Roles of METTL3 in cancer: mechanisms and therapeutic targeting

Journal of hematology and oncology, 2020-08, Vol.13 (1), p.117-15, Article 117

2020

Volltextzugriff (PDF)

Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignancies

Chinese journal of cancer research, 2023-06, Vol.35 (3), p.245-251

2023

Volltextzugriff (PDF)

Expression patterns of immune checkpoints in acute myeloid leukemia

Journal of hematology and oncology, 2020-04, Vol.13 (1), p.28-28, Article 28

2020

Volltextzugriff (PDF)

Current insight into the regulation of PD-L1 in cancer

Experimental hematology & oncology, 2022-07, Vol.11 (1), p.1-44, Article 44

2022

Volltextzugriff (PDF)

TCR engineered T cells for solid tumor immunotherapy

Experimental hematology & oncology, 2022-06, Vol.11 (1), p.1-38, Article 38

2022

Volltextzugriff (PDF)

Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells

BMC cancer, 2014-09, Vol.14 (1), Article 693

2014

Volltextzugriff (PDF)

TIM-3 in Leukemia; Immune Response and Beyond

Frontiers in oncology, 2021-09, Vol.11, p.753677-753677

2021

Volltextzugriff (PDF)

Arene Ruthenium(II) Complexes as Low-Toxicity Inhibitor against the Proliferation, Migration, and Invasion of MDA-MB-231 Cells through Binding and Stabilizing c‑myc G‑Quadruplex DNA

Organometallics, 2016-02, Vol.35 (3), p.317-326

2016

Volltextzugriff (PDF)

The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells

Molecular cancer, 2018-08, Vol.17 (1), p.130-130, Article 130

2018

Volltextzugriff (PDF)

Immune checkpoint alterations and their blockade in COVID-19 patients

Blood science, 2022-10, Vol.4 (4), p.192-198

2022

Volltextzugriff (PDF)

Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy

Journal of hematology and oncology, 2023-09, Vol.16 (1), p.1-105, Article 105

2023

Volltextzugriff (PDF)

Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis

Blood science, 2022-07, Vol.4 (3), p.152-154

2022

Volltextzugriff (PDF)

Emerging evidence and treatment paradigm of non-small cell lung cancer

Journal of hematology and oncology, 2023-04, Vol.16 (1), p.40-40, Article 40

2023

Volltextzugriff (PDF)

Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting

Experimental hematology & oncology, 2023-07, Vol.12 (1), p.62-62, Article 62

2023

Volltextzugriff (PDF)

Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia

Cancer biology & therapy, 2023-12, Vol.24 (1), p.2278229-2278229

2023

Volltextzugriff (PDF)

Editorial: The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy

Frontiers in immunology, 2023-06, Vol.14, p.1238698-1238698

2023

Volltextzugriff (PDF)

Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer

Frontiers in immunology, 2021-07, Vol.12, p.660488-660488

2021

Volltextzugriff (PDF)

PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells

Oncoimmunology, 2017-03, Vol.6 (3), p.e1284722-e1284722

2017

Volltextzugriff (PDF)

Transcriptome-Based Co-Expression of BRD4 and PD-1/PD-L1 Predicts Poor Overall Survival in Patients With Acute Myeloid Leukemia

Frontiers in pharmacology, 2021-02, Vol.11, p.582955-582955

2021

Volltextzugriff (PDF)

Higher TIGIT+ γδ TCM cells may predict poor prognosis in younger adult patients with non-acute promyelocytic AML

Frontiers in immunology, 2024-04, Vol.15, p.1321126-1321126

2024

Volltextzugriff (PDF)

Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia

Frontiers in immunology, 2024-01, Vol.14, p.1315453-1315453

2024

Volltextzugriff (PDF)

Dual role of BCL11B in T-cell malignancies

Blood science, 2024-10, Vol.6 (4), p.e00204-e00204

2024

Volltextzugriff (PDF)

Local Group 2 Innate Lymphoid Cells Promote Corneal Regeneration after Epithelial Abrasion

The American journal of pathology, 2017-06, Vol.187 (6), p.1313-1326

2017

Volltextzugriff (PDF)

Extensive exploration of T cell heterogeneity in cancers by single cell sequencing

Chinese journal of cancer research, 2019-04, Vol.31 (2), p.410-418

2019

Volltextzugriff (PDF)

HoxBlinc RNA Recruits Set1/MLL Complexes to Activate Hox Gene Expression Patterns and Mesoderm Lineage Development

Cell reports (Cambridge), 2016-01, Vol.14 (1), p.103-114

2016

Volltextzugriff (PDF)

1 – 25 von 474

Suche als RSS-Feed

Aktive Filter

ThemaLymphocytes T

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(422)
Mit Volltextzugriff
(435)

Publikationsform

Sprache

Englisch
(463)
Chinesisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Roles of METTL3 in cancer: mechanisms and therapeutic targeting

Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignancies

Expression patterns of immune checkpoints in acute myeloid leukemia

Current insight into the regulation of PD-L1 in cancer

TCR engineered T cells for solid tumor immunotherapy

Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells

TIM-3 in Leukemia; Immune Response and Beyond

Arene Ruthenium(II) Complexes as Low-Toxicity Inhibitor against the Proliferation, Migration, and Invasion of MDA-MB-231 Cells through Binding and Stabilizing c‑myc G‑Quadruplex DNA

The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells

Immune checkpoint alterations and their blockade in COVID-19 patients

Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy

Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis

Emerging evidence and treatment paradigm of non-small cell lung cancer

Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting

Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia

Editorial: The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy

Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer

PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells

Transcriptome-Based Co-Expression of BRD4 and PD-1/PD-L1 Predicts Poor Overall Survival in Patients With Acute Myeloid Leukemia

Higher TIGIT+ γδ TCM cells may predict poor prognosis in younger adult patients with non-acute promyelocytic AML

Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia

Dual role of BCL11B in T-cell malignancies

Local Group 2 Innate Lymphoid Cells Promote Corneal Regeneration after Epithelial Abrasion

Extensive exploration of T cell heterogeneity in cancers by single cell sequencing

HoxBlinc RNA Recruits Set1/MLL Complexes to Activate Hox Gene Expression Patterns and Mesoderm Lineage Development

Aktive Filter

Suchergebnisse filtern